Abstract
Acute myocardial infarction is one of the most common cardiovascular diseases. Due to the insufficiency of coronary artery blood supply, cardiomyocyte death occurs and microenvironment deteriorates, followed by mechanical-electrophysiological dysfunction in early stage and heart failure in long term. At present, treatment of myocardial infarction can improve cardiac function and reduce ventricular remodeling in a certain extent. However, it is difficult to restore cardiac function completely due to the limited regenerative capacity of cardiomyocytes. In recent years, transplantation of adipose-derived stem cells has attracted extensive attention. However, the cell survival and engraftment rate after transplantation are generally low and the therapeutic effect is not ideal. This article reviews the current situation of adipose-derived stem cells in the treatment of acute myocardial infarction and the ways and methods that may improve its therapeutic effect. Key words: Myocardial infarction; Adipose-derived stem cell; Growth factor; Drug intervention; Scaffold material
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
